Moneycontrol PRO
pharma industry
Jump to
19 Results Found
  • Veterans Unpacked | D.S. Brar: "Your network is your net worth, and your credibility is your currency" Jul 31, 2021 01:27 PM IST

    Veterans Unpacked | D.S. Brar: "Your network is your net worth, and your credibility is your currency"

    His advice to young leaders: "Focus on relationships and building trust with your customers, your partners and your employees."

  • Gland Pharma’s focus on injectables yields superior growth May 21, 2021 08:59 AM IST

    Gland Pharma’s focus on injectables yields superior growth

    Gland Pharma’s revenue growth surpassed that of frontline drug companies in FY21. It is expected to outpace industry majors in the current fiscal too

  • I am sure global pharma industry will support India's WTO proposal of IP waiver for COVID-19: Piyush Goyal Feb 25, 2021 12:47 PM IST

    I am sure global pharma industry will support India's WTO proposal of IP waiver for COVID-19: Piyush Goyal

    In October 2020, India and South Africa submitted a proposal suggesting a waiver for all WTO (World Trade Organisation) members on the implementation, application and enforcement of certain provisions of the TRIPS Agreement in relation to the prevention, containment or treatment of COVID-19.

  • Indian pharma firms go local seeking to end reliance on China Feb 23, 2021 05:45 PM IST

    Indian pharma firms go local seeking to end reliance on China

    Though India is known as the pharmacy of the world for its massive production capacities of both generic drugs and vaccines, China accounted for half of its API needs in 2019 from nearly nothing three decades ago, industry data shows.

  • Budget 2021 could be the vaccine for the pharmaceutical industry Jan 21, 2021 03:21 PM IST

    Budget 2021 could be the vaccine for the pharmaceutical industry

    Given the government’s ambition to make India a $5 trillion economy in the next five years, pharmaceutical and life science could be the ‘target sector’ in Budget 2021

  • Coronavirus pandemic | Centre to expedite clearances to bulk drug projects to fight COVID-19 Mar 12, 2020 06:28 PM IST

    Coronavirus pandemic | Centre to expedite clearances to bulk drug projects to fight COVID-19

    The notification has been sent to the Central Pollution Control Board, Expert Appraisal Committee and pollution control boards in all states and Union territories.

  • 3-Point Analysis | API export restriction: Takeaways for pharma industry Mar 05, 2020 07:37 PM IST

    3-Point Analysis | API export restriction: Takeaways for pharma industry

    Moneycontrol's Sakshi Batra does a 3-Point Analysis to understand what it means for the Indian pharma industry.

  • Indian pharma industry likely to grow at 10-13% in FY'21: ICRA Jan 28, 2020 03:35 PM IST

    Indian pharma industry likely to grow at 10-13% in FY'21: ICRA

    The expected growth in the next financial year is on the back of healthy demand from the domestic market given increasing spend on healthcare along with improving access, Icra said in a statement.

  • Editor's Take | Budget 2020: The pharma industry's wishlist Jan 24, 2020 05:05 PM IST

    Editor's Take | Budget 2020: The pharma industry's wishlist

    Shraddha Sharma gets in conversation with Corporate Bureau Chief Prince Thomas to find out the expectations of the phama sector from Finance Minister Nirmala Sitharaman in Budget 2020.

  • NPPA issues notices to Lupin, Ranbaxy, others for selling FDCs without price approval May 17, 2017 09:19 PM IST

    NPPA issues notices to Lupin, Ranbaxy, others for selling FDCs without price approval

    “These companies have launched formulations by altering a scheduled formulation with strength/dosage other than as specified in DPCO, 2013 and secondly in combination with other non-scheduled medicines without even applying for price approval from NPPA as required under Para 1 (2) of DPCO, 2013,” NPPA said.

  • Pharma: Here's what all happened in the sector last week May 14, 2017 03:21 PM IST

    Pharma: Here's what all happened in the sector last week

    Here's what happened in pharma last week

  • Budget 2017: Weighted deductions for incurring pharma R&D should continue Jan 24, 2017 04:29 PM IST

    Budget 2017: Weighted deductions for incurring pharma R&D should continue

    R&D/clinical trial services performed in India are liable to service tax at the rate of 15% even when the recipient of service is situated outside India. To lower the cost of provision of such services and to boost innovation in the country and make such services globally competitive, it is important to provide for some sort of exemption.

  • Hillary win may pose pricing challenges for pharma cos: Report Nov 07, 2016 07:58 PM IST

    Hillary win may pose pricing challenges for pharma cos: Report

    A Democrat sweep in US polls may pose even greater pricing challenges for the pharma industry and pave the way for tighter pricing regulations for both brand name and generic drugs, according to a report.

  • BJP manifesto had promised to incentivise R&D: Ketan Dalal Nov 26, 2015 09:47 PM IST

    BJP manifesto had promised to incentivise R&D: Ketan Dalal

    The Central Board Of Direct Taxation (CBDT) has now extended the time period for consultation to December 31.

  • New pricing norms may hit pharma cos' earnings: ICRA May 30, 2013 06:28 PM IST

    New pricing norms may hit pharma cos' earnings: ICRA

    With the National List of Essential Medicines (NLEM) estimated to cover almost 20 percent of the Rs 72,800 crore domestic formulation business, an expected price cut of 15-20 percent will erode the market by 3-4 percent, the ICRA report said.

  • 2012 of Pharma industry ends with debate over patents Dec 27, 2012 10:29 PM IST

    2012 of Pharma industry ends with debate over patents

    2012 was occupied by Pharma industry bodies & patient groups debated over the contours of the pricing policy. Essential drugs are getting cheaper. The Pharma pricing policy that was drafted towards the end of 2011 was just the tip of the iceberg which melted into a veritable deluge.

  • GoM vs pharma industry: Battling for market driven pricing Apr 03, 2012 10:17 PM IST

    GoM vs pharma industry: Battling for market driven pricing

    The pharma industry is on the edge of its seat with all eyes on the April 4 Group of Ministers (GoM) meeting which will decide on a final pricing policy for essential drugs, reports CNBC-TV18's Archana Shukla.

  • Pharma companies oppose inclusion of 348 drugs in NLEM Jan 06, 2012 02:53 PM IST

    Pharma companies oppose inclusion of 348 drugs in NLEM

    Union health ministry's plan to bring 348 drugs of the National List of Essential Medicines (NLEM) under price control is facing stiff resistance from the pharma industry, reports the Times of India.

  • Pfizer eyes 13-14% growth in FY11-12 Jul 19, 2011 08:25 PM IST

    Pfizer eyes 13-14% growth in FY11-12

    Pfizer, the Indian unit of drug maker Pfizer Inc, is eyeing a 13-14% growth in its revenues in the financial year 2011-12, a senior company official said today.

Sections
ISO 27001 - BSI Assurance Mark